| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |